Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Riley Hospital for Children at Indiana University Health
Cancer & Blood Diseases11700 N Meridian St
Carmel, Indiana, United States
Phone Web
The Cancer & Blood Diseases Department at Riley at IU Health works hand-in-hand with a large team of doctors and support staff from a variety of specialties to provide every possible treatment option available. The child’s care plan may involve a treatment or therapy that is provided by specialists from the following Riley at IU Health departments:
– Integrative Medicine & Palliative Care
– Neurology
– Neurosurgery
– Pain Management
– Physical Therapy & Rehabilitation
– Radiology & Imaging
The health team at Riley at IU Health cares about the child, and they also care about future children who will be affected by cancer and blood diseases. That is why the physician-scientists at Riley at IU Health and Indiana University Health University Hospital focus on research and clinical trials.
The IU Health Melvin and Bren Simon Cancer Center is the only National Cancer Institute (NCI)-designated cancer center for clinical care in Indiana. It provides the only pediatric stem cell (bone marrow) transplant program in the state and is member of the Children’s Oncology Group Phase I & Pilot Consortium. This means it receives early access to clinical trials and newly developed cancer treatments and research.
+myBinderRelated Content
-
Donald B. Kohn, MDDr. Donald Kohn, MD, is a Distinguished ...
-
Sickle Cell Disease CoalitionThe Sickle Cell Disease Coalition (SCDC)...
-
Brandon Hardesty, MDBrandon Hardesty serves as an IHTC adult...
-
Sickle cell disease in childrenSickle cell disease (SCD) is an inherite...
-
Society of Pediatric Psychology Fall Virtual ConferenceSeptember 29, 2023 | 10 a.m. to 5 p.m. E...
-
Coronavirus Questions: Getting Answers From the Expertshttps://www.youtube.com/watch?v=iFavuPKV...
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
